Ingestible device and associated methods

US11224364B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11224364-B2
Application numberUS-201715844427-A
CountryUS
Kind codeB2
Filing dateDec 15, 2017
Priority dateDec 15, 2016
Publication dateJan 18, 2022
Grant dateJan 18, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An ingestible device is disclosed which can produce spectral data of one or more analytes, as well as associated methods for characterizing the gastrointestinal tract of a subject which contains such analytes. Related kits and systems are also disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A device, comprising: a spectrometer configured to generate spectral data of gastrointestinal (GI) tract tissue of a subject in vivo; and a processing unit configured to produce a GI tract tissue health profile for the GI tract tissue based on the spectral data, wherein the processing unit is configured: i) to access a plurality of reference spectra corresponding to tissue having a specific health condition or a specific oxygenation level; and ii) to compare the spectral data with the plurality of reference spectra to determine the health condition of the GI tract tissue, and wherein the device is an ingestible device and the comparison comprises: i) comparing a magnitude of one or more spectra produced from the spectral data with a magnitude of each reference spectrum within the plurality of reference spectra; and ii) identifying the health condition of the GI tract tissue by matching the magnitude of the acquired spectrum to the magnitude of a reference spectrum corresponding to tissue having a specific health condition. 2. The device of claim 1 , wherein the spectrometer comprises a hyperspectral camera, and the spectral data comprise a hyperspectral image of the GI tract tissue. 3. The device of claim 2 , wherein the hyperspectral camera is configured to use the hyperspectral image to produce one or more spectra corresponding to the tissue. 4. The device of claim 1 , further comprising a communications unit configured to transmit data to and/or receive operating parameters from a base station. 5. The device of claim 1 , wherein the processing unit is within the device. 6. The device of claim 1 , wherein the device is configured to communicate with a processing unit within a base station that is external to the device. 7. The device of claim 1 , wherein the device and/or the base station comprises memory configured to store the spectral data and/or the GI tract tissue health profile. 8. The device of claim 1 , wherein the specific health condition comprises one or more of normal issue, inflamed tissue, scabbed tissue, and necrotic tissue. 9. The device of claim 1 , wherein the specific health condition comprises a specific oxygenation level of the GI tract tissue. 10. The device of claim 9 , wherein the oxygenation level is from about 1% to about 100%. 11. The device of claim 9 , wherein the comparison comprises: i) comparing a spectral feature of the one or more spectra with a spectral feature of each reference spectrum within the plurality of reference spectra; and ii) identifying the oxygenation level of the GI tract tissue by matching the spectral features of the one or more spectra to the spectral features of a reference spectrum corresponding to tissue having a specific oxygenation level. 12. The device of claim 1 , wherein the spectrometer is configured to acquire a spectrum corresponding to a GI tract tissue. 13. The device of claim 1 , wherein the device is configured to generate the spectral data at a predetermined region within the GI tract of the subject. 14. The device of claim 1 , wherein the device is operable to generate the spectral data at a plurality of time points as the device travels through the GI tract of the subject. 15. The device of claim 1 , wherein the spectrometer is configured to generate at least one member selected from the group consisting of absorbance spectral data, transmission spectral data, reflectance spectral data, Fourier transform spectral data, and Raman spectral data. 16. The device of claim 1 , wherein the device comprises a plurality of spectrometers configured to generate different types of spectral data. 17. The device of claim 1 , wherein the spectrometer comprises a light source and a photodetector positioned on the exterior of the device. 18. The device of claim 1 , wherein the light source is configured to transmit light radially towards an environment external to the device, and the photodetector is configured to detect a radial reflectance from the environment external to the device. 19. The device of claim 1 , wherein the spectral data comprises at least one member selected from the group consisting of ultraviolet spectral data, visible spectral data, near-infrared (NIR) spectral data, and mid-infrared (MIR) spectral data. 20. The device of claim 1 , wherein the spectrometer comprises a 2-dimensional array of photodetectors. 21. The device of claim 1 , wherein the device further comprises one or more environmental sensors for measuring environmental data external to the device. 22. The device of claim 1 , wherein the processing unit is configured to identify a location of the device within the GI tract of the subject based on the spectral data. 23. The device of claim 1 , wherein the device is configured to attach to the GI tract of the subject in vivo. 24. A method, comprising: using a spectrometer to generate in situ spectral data of a gastrointestinal (GI) tract of a subject; and generating a GI tract tissue health profile for the subject based on the in situ spectral data of the GI tract tissue by: accessing a plurality of reference spectra corresponding to tissue having a specific health condition or a specific oxygenation level; and comparing the spectral data with the plurality of reference spectra to determine the health condition of the GI tract tissue by: comparing a magnitude of one or more spectra produced from the spectral data with a magnitude of each reference spectrum within the plurality of reference spectra; and identifying the health condition of the GI tract tissue by matching the magnitude of the acquired spectrum to the magnitude of a reference spectrum corresponding to tissue having a specific health condition, wherein the spectral data indicate whether a bleed is present in the GI tract. 25. The method of claim 24 , wherein the spectral data indicate whether hemoglobin and/or a red blood cell is present in the GI tract. 26. The method of claim 24 , wherein the spectral data comprise wavelengths in a range of 400 nm to 680 nm. 27. The method of claim 24 , wherein the spectral data comprise wavelengths in a range of 500 nm to 650 nm. 28. The method of claim 24 , wherein the spectral data comprise wavelengths of 545 nm to 580 nm. 29. The method of claim 24 , the spectral data indicate a concentration of blood in the GI tract of from 0 to 3.5%. 30. A device, comprising: a spectrometer configured to generate spectral data of gastrointestinal (GI) tract tissue of a subject in vivo; and a processing unit configured to determine, based on the spectral data, whether blood in meals is present in the GI tract by: accessing a plurality of reference spectra corresponding to blood in meals being present in the GI tract; and comparing the spectral data with the plurality of reference spectra to determine blood in meals being present in the GI tract by: comparing a magnitude of one or more spectra produced from the spectral data with a magnitude of each reference spectrum within the plurality of reference spectra; and identifying blood in meals being present in the GI tract by matching the magnitude of the acquired spectrum to the magnitude of a reference spectrum corresponding to to blood in meals being present in the GI tract, wherein the device is an ingestible device. 31.

Assignees

Inventors

Classifications

  • of image signals during a use of endoscope · CPC title

  • for radial illumination · CPC title

  • Capsule endoscopes for imaging · CPC title

  • for 90 degrees side-viewing · CPC title

  • using artificial intelligence · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11224364B2 cover?
An ingestible device is disclosed which can produce spectral data of one or more analytes, as well as associated methods for characterizing the gastrointestinal tract of a subject which contains such analytes. Related kits and systems are also disclosed.
Who is the assignee on this patent?
Progenity Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/1459. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).